Skip to main content
. 2018 Oct 24;7(12):5920–5927. doi: 10.1002/cam4.1840

Figure 2.

Figure 2

Kaplan‐Meier analysis of progression‐free survival (PFS) and overall survival (OS) in group of patients with differential expression of  CD117 and CD81. (a) CD117(+)CD81(−) patients compared with CD117(−)CD81(−)/CD117(+)CD81(+) patients, (b) CD117(+)CD81(−) patients compared with CD117‐CD81+, (c) overall comparison. A, PFS of CD117(+) patients and CD117(−) patients. B, OS of CD117(+) patients and CD117(−) patients. C, PFS of CD81(+) patients and CD81(−) patients. D, OS of CD81(+) patients and CD81(−) patients. E, PFS of CD117(+)CD81(−), CD117(−)CD81(−)/CD117(+)CD81(+), and CD117(−)CD81(+) patients. F, OS of CD117(+)CD81(−), CD117(−)CD81(−)/CD117(+)CD81(+), and CD117(−) CD81(+) patients